Medical Equipment

Biopharmaceutical Tubing Market Trends and Insights: Global Forecast to 2030

January 30, 2026January 30, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the neuro immunoassay market from 2026–2035 with trusted insights from The Business Research Company

What long-term size projections exist for the Biopharmaceutical Tubing Market covering 2026–2035?

The biopharmaceutical tubing market has experienced substantial expansion in recent years. Its size is projected to increase from $4.79 billion in 2025 to $5.32 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 11.2%. Historically, this growth has been driven by several factors, including the expansion of biopharmaceutical manufacturing capacity, the increasing standardization of sterile processing components, the early adoption of silicone and pvc tubing in drug production lines, an increase in contract manufacturing and fill-finish activities, and a growing regulatory focus on material biocompatibility and purity.

The biopharmaceutical tubing market is projected to experience substantial expansion in the coming years, with its valuation set to reach $8.12 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 11.1%. This anticipated growth throughout the forecast period stems from factors such as an expanding pipeline of biologics, cell, and gene therapy products, a growing move towards single-use and disposable processing systems, increased demand for high-performance TPE and polyolefin tubing, the wider adoption of automated production and closed system workflows, and increased investment in sophisticated bioprocessing and aseptic transfer technologies. Key trends expected during this period involve the increasing incorporation of high-purity and biocompatible tubing in biopharmaceutical processes, the rising acceptance of single-use and sterile transfer tubing systems, a growing need for precise fluid handling in drug manufacturing and fill-finish procedures, the broader application of tubing across pharmaceutical, medical device, and R&D environments, and an emphasis on material longevity, sterility guarantees, and robust contamination control.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18525&type=smp

Which Drivers Are Impacting The Competitive Landscape Of The Biopharmaceutical Tubing Market?

The rising number of personalized medicines is projected to stimulate the growth of the biopharmaceutical tubing market moving forward. Personalized medicine signifies a healthcare strategy that customizes medical decisions, practices, interventions, and treatments according to the distinct characteristics of each patient. This field has gained prominence due to genetic research, which enables tailored treatment approaches based on an individual’s genetic profile, lifestyle, and specific health conditions. Biopharmaceutical tubing supports personalized medicine by providing precise, sterile, and reliable fluid transfer, which is essential for delivering customized treatments and therapies unique to individual patient profiles. For example, in February 2024, the U.S. Food and Drug Administration (FDA) approved 26 new personalized therapies in 2023, an increase from 18 in 2022, according to the Personalized Medicine Coalition, a US-based non-profit organization, marking one of the highest annual gains in personalized medicine approvals. Therefore, the increasing volume of personalized medicines is fueling the expansion of the biopharmaceutical tubing market.

What Segments Are Identified Within The Structure Of The Biopharmaceutical Tubing Market?

The biopharmaceutical tubing market covered in this report is segmented –

1) By Product: Silicone Tubing, Polyvinyl Chloride (PVC) Tubing, Polyolefin Tubing, Thermoplastic Elastomer Tubing

2) By Manufacturing Process: Extrusion, Vulcanization, Other Manufacturing Processes

3) By Application: Pharmaceutical, Medical Devices, Research And Development, Other Applications

Subsegments:

1) By Silicone Tubing: Medical-Grade Silicone Tubing, Platinum-Cured Silicone Tubing, Peroxide-Cured Silicone Tubing

2) By Polyvinyl Chloride (Pvc) Tubing: Clear Pvc Tubing, Non-Dehp Pvc Tubing, Soft Pvc Tubing

3) By Polyolefin Tubing: Cross-Linked Polyolefin Tubing, Low-Density Polyethylene Tubing, High-DDensity Polyethylene Tubing

4) By Thermoplastic Elastomer Tubing: Medical-Grade Tpe Tubing, Elastomeric Tpe Tubing, Biocompatible Tpe Tubing

Which Trends Are Guiding The Evolution Of The Biopharmaceutical Tubing Market?

Leading companies in the biopharmaceutical tubing market are developing advanced customizable solutions, such as bioabsorbable tubing, to improve performance, enhance sterility, and optimize fluid handling for sophisticated biopharmaceutical applications. Bioabsorbable tubing refers to specialized tubes made from materials that gradually break down and are absorbed by the body over time, eliminating the need for removal after use. For instance, in September 2023, Zeus Company Inc., a US-based advanced polymer solutions provider, launched the Absorv XSE-oriented tubing, a next-generation bioabsorbable product specifically designed for bioresorbable vascular scaffolds (BRS). This development empowers medical device manufacturers to explore BRS applications beyond just coronary artery disease treatment and potentially replace metallic stents in various procedures. The new tubing offers improved uniformity in both wall thickness and sizing, which leads to greater efficiency during laser cutting processes, ultimately resulting in more usable scaffolds.

Which Major Firms Are Strengthening Their Position In The Biopharmaceutical Tubing Market?

Major companies operating in the biopharmaceutical tubing market are Compagnie de Saint-Gobain S.A., Thermo Fisher Scientific Inc., Merck KGaA, GE HealthCare Technologies Inc., Parker Hannifin Corporation, DuPont de Nemours Inc., Freudenberg Group, Alfa Laval AB, REHAU Group, W. L. Gore & Associates Inc., Sartorius AG, Elkem ASA, Trelleborg AB, Bio-Rad Laboratories Inc., Tekni-Plex Inc., Pall Corporation, Zeus Company Inc., Watson-Marlow Ltd., Raumedic AG, Optinova AB, ESI Ultrapure

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/biopharmaceutical-tubing-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The Biopharmaceutical Tubing Market?

North America was the largest region in the biopharmaceutical tubing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biopharmaceutical tubing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Biopharmaceutical Tubing Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=18525&type=smp

Browse Through More Reports Similar to the Global Biopharmaceutical Tubing Market 2026, By The Business Research Company

Biopreservation Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/biopreservation-global-market-report

Membrane Filtration Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/membrane-filtration-global-market-report

Biopharmaceutical Cmo Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/biopharmaceutical-cmo-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795